1.Predominant tubulointerstitial lupus nephritis in a case.
Jian-ping HUANG ; Xin LI ; Jing-jing ZHANG ; Yuan-hua ZONG ; Jing-cheng LIU ; Ji-yun YANG
Chinese Journal of Pediatrics 2004;42(3):221-221
Child
;
Humans
;
Lupus Nephritis
;
complications
;
Male
;
Nephritis, Interstitial
;
etiology
;
Prognosis
4.Treatment of thoracic and abdominal cavity perforation complicated by Henoch-Schonlein purpura nephritis in a patient with high-voltage electric burn.
Wei ZHANG ; Wei-guo XIE ; Wei-xiong MIN ; De-yun WANG ; Jia ZHANG ; Shi-yong WAN
Chinese Journal of Burns 2013;29(5):454-458
A 55-year-old male patient suffered from severe high-voltage electric burn with an area of 20%TBSA full-thickness injury. The injury involved the distal end of left upper limb, right trunk, and whole abdominal wall. Fracture of the 7th-10th ribs was found in the right side of chest, with perforation of abdominal cavity, and bilateral pleural effusion was found. Part of the small intestine was necrotic and exposed. At the early stage, xeno-acellular dermal matrix was grafted after debridement of abdominal wound; peritoneal lavage was performed; negative pressure drainage was performed in orificium fistula of intestine for promoting the adhesion between perforated intestine and abdominal scar. Two orificium fistulas formed after closure of abdominal granulation wound by autologous skin grafting. Eschar of chest wall and denatured ribs were retained. The risk of infection of thoracic cavity was decreased by promoting the adhesion between lung tissue and chest wall. During the treatment, the patient was diagnosed with Henoch-Schonlein purpura nephritis by renal biopsy, with the symptoms of purpura in the lower limbs, heavy proteinuria, severe hypoalbuminemia, edema, etc. After control of kidney damage by immunosuppressive treatment instead of glucocorticoid, alleviation of the levels of proteinuria and blood albumin, free latissimus dorsi myocutaneous flap was excised to repair chest wall, and free skin graft was excised to repair intestinal fistula. After all the wounds were successfully covered, the patient was treated with glucocorticoid combined with immunosuppressants for more than 1 year. The patient was followed up for 3 years, and his renal function was completely recovered with satisfactory clinical outcome.
Abdominal Cavity
;
Abdominal Injuries
;
complications
;
surgery
;
Burns, Electric
;
complications
;
surgery
;
Humans
;
Male
;
Middle Aged
;
Nephritis
;
complications
;
surgery
;
Purpura, Schoenlein-Henoch
;
complications
;
surgery
;
Thoracic Cavity
;
Thoracic Injuries
;
complications
;
surgery
6.Treatment of Primary Sjögren's Syndrome Complicated Nephritis of Henoch-Schonlein Purpura: a Case Report of One Case.
Chang-chang LIANG ; Qiao-qiao LIU ; Tian YU
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(12):1526-1527
Humans
;
Nephritis
;
etiology
;
therapy
;
Prognosis
;
Purpura, Schoenlein-Henoch
;
complications
;
therapy
;
Sjogren's Syndrome
;
etiology
;
therapy
7.Intensive reading of evidence-based guidelines on diagnosis and treatment of childhood common renal diseases (II).
Song-ming HUANG ; Qiu LI ; Yan-fang GUO
Chinese Journal of Pediatrics 2009;47(12):914-916
Child
;
Evidence-Based Medicine
;
Humans
;
Nephritis
;
diagnosis
;
etiology
;
therapy
;
Practice Guidelines as Topic
;
Purpura
;
complications
;
diagnosis
;
therapy
9.COL4A5 genotypes and clinical characteristics of children with Alport syndrome.
Wei HUANG ; Cui-Hua LIU ; Ji-Tong LI ; Yu-Jie LIU ; Yu-Liu LI ; Ming TIAN ; Guang-Hai CAO ; Shu-Feng ZHANG
Chinese Journal of Contemporary Pediatrics 2023;25(7):732-738
OBJECTIVES:
To investigate the genotypes of the pathogenic gene COL4A5 and the characteristics of clinical phenotypes in children with Alport syndrome (AS).
METHODS:
A retrospective analysis was performed for the genetic testing results and clinical data of 19 AS children with COL4A5 gene mutations.
RESULTS:
Among the 19 children with AS caused by COL4A5 gene mutations, 1 (5%) carried a new mutation of the COL4A5 gene, i.e., c.3372A>G(p.P1124=) and presented with AS coexisting with IgA vasculitis nephritis; 3 children (16%) had large fragment deletion of the COL4A5 gene, among whom 2 children (case 7 had a new mutation site of loss51-53) had gross hematuria and albuminuria at the onset, and 1 child (case 13 had a new mutation site of loss3-53) only had microscopic hematuria, while the other 15 children (79%) had common clinical phenotypes of AS, among whom 7 carried new mutations of the COL4A5 gene. Among all 19 children, 3 children (16%) who carried COL4A5 gene mutations also had COL4A4 gene mutations, and 1 child (5%) had COL4A3 gene mutations. Among these children with double gene mutations, 2 had gross hematuria and proteinuria at the onset.
CONCLUSIONS
This study expands the genotype and phenotype spectrums of the pathogenic gene COL4A5 for AS. Children with large fragment deletion of the COL4A5 gene or double gene mutations of COL4A5 with COL4A3 or COL4A4 tend to have more serious clinical manifestations.
Humans
;
Nephritis, Hereditary/pathology*
;
Hematuria/complications*
;
Retrospective Studies
;
Collagen Type IV/genetics*
;
Genotype
;
Mutation
10.A Case of Systemic Lupus Erythematosus Presenting as Malignant Hypertension with Hypertensive Retinopathy.
Jung Yoon CHOE ; Sung Hoon PARK ; Ji Young KIM ; Hyun Young JUNG ; Seong Kyu KIM
The Korean Journal of Internal Medicine 2010;25(3):341-344
The variability of cardiovascular abnormalities is one of the characteristics of systemic lupus erythematosus (SLE). Among the cardiovascular manifestations, hypertension is reported in 14% to 58.1% of patients in diverse ethnic populations, and remains a clinically important issue due to its close relationship with early mortality in patients with SLE. The development of hypertension in patients with SLE has been associated with advanced lupus-related renal disease and the medications used for the treatment of lupus. Malignant hypertension is a serious complication of hypertension; it rarely occurs in patients with SLE. However, it can occur in patients with other complicated medical conditions such as the antiphospholipid antibody syndrome (APS) or cardiac tamponade. Here, we report the case of a patient with SLE and malignant hypertension with hypertensive retinopathy that initially presented without clinical evidence of APS or hypertensive nephropathy.
Adult
;
Female
;
Humans
;
Hypertension, Malignant/*diagnosis/*etiology
;
Lupus Erythematosus, Systemic/*complications/*diagnosis
;
Lupus Nephritis/complications/diagnosis
;
Retinal Diseases/*diagnosis/*etiology